{{Rsnum
|rsid=6587852
|Chromosome=1
|position=59239775
|Orientation=plus
|GMAF=0.225
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 4.4 | 31.0 | 64.6
| HCB | 2.2 | 19.1 | 78.7
| JPT | 3.6 | 35.7 | 60.7
| YRI | 16.4 | 43.8 | 39.7
| ASW | 8.8 | 31.6 | 59.6
| CHB | 2.2 | 19.1 | 78.7
| CHD | 4.7 | 30.8 | 64.5
| GIH | 5.2 | 36.5 | 58.3
| LWK | 12.0 | 50.0 | 38.0
| MEX | 0.0 | 15.5 | 84.5
| MKK | 18.1 | 40.6 | 41.3
| TSI | 5.1 | 40.4 | 54.5
| HapMapRevision=28
}}[[rs6587852]] is one of 6 SNPs found upstream of an (uncharacterized) gene known as FLJ10986 that have been found to be overrepresented in 1,152 patients with sporadic amyotrophic lateral sclerosis ([[ALS]]).{{PMID|17671248}}

{{PMID|19177248}} A study involving a large case-control series from the Netherlands, Belgium, Sweden and Ireland (total: 1883 sporadic ALS patients and 2063 controls) found no significant association between sporadic ALS and the six previously reported associated SNPs, including this one.

{{PMID Auto
|PMID=19922138
|Title=Analysis of FGGY as a risk factor for sporadic amyotrophic lateral sclerosis
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}